Extending the chimeric receptor-based T-cell targeting strategy to solid tumors

    loading  Checking for direct PDF access through Ovid


The adoptive transfer of T cells expressing chimeric antigen receptors (CARs) has emerged as a promising immunotherapeutic strategy against cancer. Administering CAR-expressing T cells in combination with agents that promote the expression of CAR targets or optimize T-cell function within the tumor microenvironment may further improve the therapeutic potential of this approach.

Related Topics

    loading  Loading Related Articles